Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 23, 17 Issues, 2022
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Contents

Current Drug Targets , Volume 22 - Number 17


Review Article (Mini-Review)

Dysregulation of Lysyl Oxidases Expression in Diabetic Nephropathy and Renal Cell Carcinoma

, 22(17): 1916 - 1925

Carolina Añazco*, Sebastián Cerro, Nicolás Pereira, Camila Rojas, Álvaro Torres and Isabel Vidal-Beltrán


DOI: 10.2174/1389450122666210712163702




Review Article

Revealing Insights into Natural Products Against mcr-1-Producing Bacteria

, 22(17): 1964 - 1985

Ana Beatriz Souza Flor dos Santos, Manuele Figueiredo da Silva, João Xavier de Araújo-Júnior and Edeildo Ferreira da Silva-Júnior *


DOI: 10.2174/1389450122666210415102413






Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog